advertisement
E-mail Page
Print Format
Google - Traducir esta página a español.
Google - Traduza esta página ao português.
 

  Back to Ask the Diabetes Team Ask the Diabetes Team
Question:

From Mumbai, Maharastra, India:

Is there any permanent treatment for this dreadful disease possible in the near future (one to two years)? Is there a possibility of temporary diabetes occurring in a child?

Answer:

I don't foresee a permanent (i.e. 'restitutio ad integrum' that is no more diet nor exogenous insulin need forever) treatment for type 1 diabetes over the next one to two years. This because either genetic therapy as well as islet cell transplants require a longer period of time to be safe for patients beyond the ongoing preclinical trials. You should review our many previous answers on these therapeutical approaches.

In the meantime, current insulin therapy, optimized towards the best metabolic control, is the safest procedure to stay healthy enough when the magic bullet will be definitively available.

The only transient form of diabetes occurring in a child is TNDM (transient neonatal diabetes mellitus) that lasts only for a short period after birth, two to three months.

MS

[Editor's comment: Please see: Research into a Cure. SS]

DTQ-20001229224002
Original posting 15 Jan 2001
Posted to Research: Cure

  
advertisement


 
Not Helpful  1 2 3 4 5  Very Helpful                  E-mail Article E-mail Page     Printer Friendly format Print Format    
  Home Return to Top

Last Updated: Tuesday April 06, 2010 15:09:16
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

US Flag This site is published by Children With Diabetes, Inc, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, Privacy Policy, and Safe Harbor Policy.
© Children with Diabetes, Inc. 1995-2012. Comments and Feedback.